(Q40316854)

19 September 2017

Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells (English)

1 reference

19 September 2017

1 reference

1 reference

Tsao CW

1

1 reference

19 September 2017

Lin YS

2

1 reference

19 September 2017

Cheng JT

3

1 reference

19 September 2017

Chang WW

4

1 reference

19 September 2017

Chen CL

5

1 reference

19 September 2017

Wu SR

6

1 reference

19 September 2017

Fan CW

7

1 reference

19 September 2017

Lo HY

8

1 reference

19 September 2017

language of work or name

1 reference

1 February 2006

1 reference

Scandinavian Journal of Immunology

19 September 2017

1 reference

19 September 2017

63

1 reference

19 September 2017

2

1 reference

19 September 2017

106-115

1 reference

Hepatitis B virus: old, new and future approaches to antiviral treatment

19 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Antiviral therapy for chronic hepatitis B: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Side effects of alpha interferon in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Hepatitis C, interferon alfa, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Serotonin transporter: a potential substrate in the biology of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Expression of a high-affinity serotonin transporter in human lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Presence and characterization of the serotonin transporter in human resting lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Lymphocytes as a neural probe: potential for studying psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Serotonin transporter modulation in blood lymphocytes from patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Phosphorylation and regulation of antidepressant-sensitive serotonin transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Regulation of the human serotonin transporter by interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Serotonin and its transporter on proliferation of fetal heart cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01715.X

10.1111/J.1365-3083.2005.01715.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference